EPISKIN
- Company typePrivate
- Founded1997
- HeadquartersLyon, France
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
EPISKIN firmographics
Firmographics- Name
- EPISKIN
- Legal name
- EPISKIN SA
- Website
- https://episkin.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Ownership category
- akta.pro rank
EPISKIN industry classification
Industry- Product category
- In Vitro Tissue Engineering and Reconstructed Human Tissue Models
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where EPISKIN is headquartered
LocationHeadquarters
- HQ city
- Lyon
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
EPISKIN business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Reconstructed Human Tissue Products: EPISKIN generates revenue from the sale of its reconstructed human skin and epithelial tissue models. The company produces and sells a range of models including T-Skin (Full Thickness), SkinEthic RHE, RHE-LC, RHPE, HCE, HO2E, HGE, HBE, and HVE. These are sold as ready-to-use in vitro tissue models in various formats including 6-well plates, HTS 24-well plates, and HTS 96-well plates.
- Training Services: EPISKIN Academy provides paid training sessions at the Lyon facility, offering one-and-a-half day courses covering reconstructed model usage, validated protocol implementation (OECD TG431, TG439), and hands-on exercises. Sessions are limited to 4 trainees for personalized interaction. Over 1,600 experts trained worldwide across 72 training sessions since 2012.
- Customized Testing Services: EPISKIN offers customized testing strategies and dedicated customer service for designing innovative protocols. The customer service team brings 25 years of internal expertise in producing and using the models to assist clients in specific testing needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Custom quotation-based pricing for reconstructed tissue models |
| Other | Multi-year contract | Training sessions at EPISKIN Academy (Lyon facility) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
EPISKIN product offering
Product offeringCore offering
EPISKIN manufactures and sells patented in vitro reconstructed human tissue models, including full-thickness skin (T-Skin) and multiple epithelial tissues (SkinEthic RHE, RHE-LC, RHPE, HCE, HO2E, HGE, HBE, HVE), produced in ISO6 clean rooms via proprietary air-liquid-interface cell-culture processes. The company also provides EPISKIN Academy training services and customized testing protocols validated under OECD Test Guidelines.
Product overview
EPISKIN is a world leader in tissue engineering offering a comprehensive portfolio of human reconstructed tissues for in vitro testing. The product portfolio centers on eight distinct epithelial models: T-Skin (full thickness skin model), SkinEthic RHE (human epidermis), SkinEthic RHE-LC (epidermis with Langerhans cells), SkinEthic RHPE (pigmented epidermis), SkinEthic HCE (corneal epithelium), SkinEthic HO2E (oesophageal epithelium), SkinEthic HGE (gingival epithelium), SkinEthic HBE (bladder epithelium), and SkinEthic HVE (vaginal epithelium). These models support safety and efficacy evaluation for cosmetics, pharmaceutical, and chemical industries. The company also provides EPISKIN Academy for training and EPISKIN TV for educational content. All models are produced in ISO 9001 certified facilities with validated protocols aligned to OECD Test Guidelines.
Differentiator
Problem solved
Functional benefit
Brands
- SkinEthic: Product line of reconstructed human epithelial models including RHE, RHE-LC, RHPE, HCE, HO2E, HGE, HBE, and HVE for various testing applications.
- T-Skin
- EPISKIN Academy
Products and services
- T-Skin / Human Full Thickness Skin Model
Quantifiable outcome
- 85% overall accuracy in skin irritation testing validated by ECVAM (80% specificity, 90% sensitivity)
- +2 more outcomes
Companies that use EPISKIN
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
EPISKIN technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature13 records
EPISKIN partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and regional.
- L'Oréal Research & InnovationcoreEPISKIN is a subsidiary of L'Oréal, operating as a separate company (EPISKIN SA) while maintaining close ties to L'Oréal Research & Innovation. L'Oréal developed many of the core technologies and validated test methods including SkinEthic HCE EIT and HCE Time-to-Toxicity. EPISKIN is branded as 'Episkin / L'Oréal Research & Innovation' on its website. The company benefits from L'Oréal's 25+ years of tissue engineering expertise and R&D infrastructure.
- Nikoderm Research Co, LtdregionalAuthorized partner for EPISKIN products in Japan. Located at 1-6-14 Azuchimachi, Chuo-ku, Osaka City, Osaka 541-0052, Japan. Phone: 06-6125-3501. Contact: [email protected]. Website: www.nikoderm.com/
- Krishgen BiosystemsregionalAuthorized partner for EPISKIN products in India. Located at 318/319 Shah & Nahar Industrial Estate, Worli 400018, Mumbai, India. Phone: (022) 49198700. Website: www.krishgen.com
- Dowell C&IregionalAuthorized partner for EPISKIN products in Korea. Located at Yeojundo Center 415, Yulgok-ro 190, Jongno-gu, Seoul, 110-738, Korea. Phone: +82-2-536-1715. Contact: [email protected]
Scale indicators7 records
Recent moves8 records
Expansion highlights6 records
EPISKIN competitors and assessment
Company assessmentEmerging players
- CN Bio Innovations: CN Bio develops microphysiological systems and organ-on-chip platforms for drug development and toxicology testing. It is an emerging alternative to EPISKIN's reconstructed tissue models for in vitro safety and efficacy testing.
- Emulate Inc. Emulate develops organ-on-chip technology that competes with traditional reconstructed tissue models like EPISKIN's for predictive toxicology applications. It represents an emerging alternative that could erode EPISKIN's market position as organ-on-chip gains regulatory acceptance.
- BICO (CELLINK): BICO is a bioconvergence company offering bioprinting and tissue engineering solutions that could complement or compete with EPISKIN's reconstructed tissue models, particularly in research and drug discovery applications.
Others
- Skin Analytics: Skin Analytics is a UK-based dermatology AI company. While operating in a different domain (clinical AI for skin lesion assessment), it serves the same dermatology research and pharmaceutical customer base as EPISKIN and represents an adjacent ecosystem participant.
Direct peers
- MatTek Corporation: MatTek produces EpiDerm, a reconstructed human epidermal model that is the most direct competitor to EPISKIN's SkinEthic RHE. Both supply OECD-validated in vitro skin models for irritation, corrosion, and other toxicology endpoints to cosmetics, pharmaceutical, and chemical industries.
- Stratatech (Mallinckrodt): Stratatech develops engineered human skin substitutes (StrataGraft) for both clinical wound healing and in vitro testing applications, overlapping with EPISKIN's tissue engineering expertise in reconstructed human skin models.
Broad incumbents
- Organogenesis Holdings: Organogenesis is a larger regenerative medicine company focused on advanced wound care and surgical biologics using skin and tissue technologies. While mainly commercial, its tissue engineering capabilities overlap with EPISKIN's broader portfolio of skin and epithelial models.
- Eurofins Scientific: Eurofins is a global contract testing CRO that serves the same cosmetics, pharmaceutical, and chemical industries EPISKIN serves. While not a tissue model producer, it is a major buyer of in vitro models and offers downstream testing services built on platforms like EPISKIN's.
- Charles River Laboratories: Charles River is a major CRO that provides preclinical and toxicology services, including in vitro testing for cosmetics and chemicals. It uses reconstructed tissue models from suppliers like EPISKIN for its contract testing service offerings.
- Labcorp Drug Development: Labcorp is a major CRO that purchases in vitro skin and epithelial models like EPISKIN's for pharmaceutical and chemical safety testing. Its central laboratory and early development services overlap with EPISKIN's downstream customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
EPISKIN social profiles
Digital presenceEPISKIN compliance and trust
Trust signalCompliance6 records
EPISKIN financial estimates
Financial estimateRevenue estimate
Valuation estimate
EPISKIN leadership team
Management profileNumber of profiles
Profiles1 record
EPISKIN funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EPISKIN M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EPISKIN
What does EPISKIN do?
EPISKIN manufactures and sells patented in vitro reconstructed human tissue models, including full-thickness skin (T-Skin) and multiple epithelial tissues (SkinEthic RHE, RHE-LC, RHPE, HCE, HO2E, HGE, HBE, HVE), produced in ISO6 clean rooms via proprietary air-liquid-interface cell-culture processes. The company also provides EPISKIN Academy training services and customized testing protocols validated under OECD Test Guidelines.
Is EPISKIN a public or private company?
EPISKIN is a private company. It is classified as corporate owned and is currently operating.
When was EPISKIN founded?
EPISKIN was founded in 1997.
Where is EPISKIN based?
EPISKIN is headquartered in Lyon, France, in the Europe region.
How does EPISKIN make money?
Three revenue lines are on record. Reconstructed Human Tissue Products are the primary driver. The others are training Services and customized Testing Services.
Who are EPISKIN's main competitors?
Emerging players on record are CN Bio Innovations, Emulate Inc. and BICO (CELLINK). Skin Analytics is listed as an others. Direct peers are MatTek Corporation and Stratatech (Mallinckrodt). Broad incumbents are Organogenesis Holdings, Eurofins Scientific, Charles River Laboratories and Labcorp Drug Development.
Does EPISKIN have an API?
No public API is recorded for EPISKIN.
What industry is EPISKIN in?
EPISKIN's product category is In Vitro Tissue Engineering and Reconstructed Human Tissue Models. Its primary akta.pro industry code is HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 325414 and its SIC code is 2836.